![](en_US" property="og:locale">
<meta content="Vesalius" property="og:site_name">
<meta content="website" property="og:type">
<meta content="https://vesaliustx.com/" property="og:url">
<meta content="Home" property="og:title">
<meta content="At Vesalius Therapeutics, we believe it is time to re-think and redefine how we treat common illnesses. Founded by Flagship Pioneering , we are building a…" property="og:description">
<meta content="https://s3.us-east-1.amazonaws.com/vesalius-craftcms-assets/uploads/_1200x630_crop_center-center_82_none/Logo-Vesalius-Therapeutics@2x.png?mtime=1646097278){kind=logo}
Vesalius Therapeutics
Pioneering breakthrough treatments for common diseases
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- vesaliustx.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series CMar 2022
- Rounds
- 1
About
Founded in 2020 and headquartered in Cambridge, Massachusetts, Vesalius Therapeutics discovers and develops drugs by targeting biological circuits within cells to treat diseases underlying common illnesses such as Parkinson's disease. The company is backed by Flagship Pioneering and has a strategic alliance with GSK to develop novel Parkinson's disease treatments.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
$75.0M
Mar 2022
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account